Pharma & Biotech Industry
Confident biomarker data for drug development and validation
Drug development requires precise and reproducible biomarker data to guide decisions across discovery, preclinical, and clinical phases.
Attoquant Diagnostics provides targeted quantification of peptides, enzymes, and small molecules to support biomarker validation, PK/PD
studies, and mechanism-of-action analyses.
Our assays are designed for robustness, scalability, and regulatory-relevant documentation.
What we support
Biomarker discovery and validation
PK/PD and target engagement studies
Custom assay development for proprietary compounds
What you gain
High-confidence data for go/no-go decisions
Flexible, project-oriented collaboration
Experienced support across development stages
Accelerate biomarker validation and drug development with precise, LC-MS/MS-based quantification. Our analytical expertise supports confident decision-making throughout the R&D pipeline.
Get in touch
Visit us
Attoquant Diagnostics GmbH
Brehmstraße 14A
1110 Vienna
Austria
Contact us
Tel: 0043 (0)660 668 58 96
Calendly: Book an appointment
Visit us on LinkedIn ![]()